Oxford’s Covid-19 vaccine could be ready by December

New Delhi, Oct 29: The Covid-19 vaccine 'Covishield', being developed by Oxford University, and manufactured by the Serum Institute of India (SII), could be ready as early as December.

Adar Poonawalla, CEO of Serum Institute, in an interview with NDTV, further said the first batch of 100 million doses should be available by the second or third quarter of 2021.

"If we don't go for an emergency license, our trials should be over by December and then we can maybe we can launch in India in January subject to the UK trial, which is on the verge of being completed," Poonawalla said.